37 results
Treatment Approach to Hodgkin's Lymphoma

By Matthew Ho, MD PhD @MatthewHoMD
With Credit: Dr Sunita Nasta and Dr
Treatment Approach ... Svoboda Ref: NCCN guidelines ... Lymphoma #oncology #Hematology ... #management #treatment ... #guideline
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021
Polyangiitis (MPA) - ANCA ... - ACR/VF 2021 Guidelines ... Vasculitis #Management #Treatment ... #ACR2021 #Guidelines ... #algorithm #rheumatology
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
Polyangiitis (EGPA) - ANCA ... - ACR/VF 2021 Guidelines ... #Polyangiitis #ANCA ... Vasculitis #Management #Treatment ... #algorithm #rheumatology
Rheumatoid Arthritis - ACR 2021 Guidelines
 - Low Disease Activity
 - Moderate to High Disease Activity
Arthritis - ACR 2021 Guidelines ... Tapering DMARDs - Treatment ... Arthritis #ACR2021 #Guidelines ... #management #treatment ... #rheumatology
Microscopic Colitis - AGA Guideline Management ALgorithm

#Microscopic #Colitis #Management #Treatment #algorithm #gastroenterology
Colitis - AGA Guideline ... Colitis #Management #Treatment ... #algorithm #gastroenterology
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
- ACR/VF 2021 Guidelines ... for Treatment & ... Vasculitis #Management #Treatment ... #ACR2021 #Guidelines ... #algorithm #rheumatology
Bleeding risk calculators - HAS-BLED (atrial fibrillation) and IMPROVE (VTE prophylaxis for inpatients)
Important notes:
 • No
and IMPROVE (VTE prophylaxis ... validated for VTE treatment ... , only for prophylaxis ... Anticoagulation #Factors #Hematology
Polyarteritis Nodosa (PAN) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Severe Disease → Remission
- ACR/VF 2021 Guidelines ... Vasculitis #Management #Treatment ... #ACR2021 #Guidelines ... #algorithm #rheumatology
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary
 • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
Workup: - ANA ... 50-60% - pANCA ... life-threatening • Treatment ... Management #Summary #rheumatology
Proposed treatment algorithm for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis

#anca #vasculitis #treatment #algorithm #rheumatology #nephrology
Proposed treatment ... cytoplasmic antibody (ANCA ... vasculitis #anca ... #vasculitis #treatment ... #algorithm #rheumatology